Literature DB >> 21771414

Mast cell stabilizing and antiallergic activity of Abrus precatorius in the management of asthma.

D J Taur1, R Y Patil.   

Abstract

OBJECTIVE: To investigate effects of ethanol extract of Abrus precatorius leaves (EAPL) on egg albumin induced mast cell degranulation in mice and passive cutaneous anaphylaxis in rats.
METHODS: In present study ethanol extract of Abrus precatorius leaves (EAPL) at doses of 100, 125, 150 mg/kg i.p were evaluated for preliminary phytochemical screening, acute toxicity studies and egg albumin induced mast cell degranulation in mice and passive cutaneous anaphylaxis in rats.
RESULTS: The results of present investigation showed that the LD(50) of EAPL is more than 1 300 mg/kg. EAPL (100-150 mg/kg, i.p.) significantly protect egg albumin induced degranulation of mast cell and inhibit area of leakage of dye in passive cutaneous anaphylaxis. Phytochemical studies observed presence of saponin, alkaloids, flavonoids, and glycosides.
CONCLUSIONS: In conclusion EAPL possesses anti asthmatic potential.
Copyright © 2011 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771414     DOI: 10.1016/S1995-7645(11)60030-8

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  9 in total

Review 1.  Ethno botanical and Phytophrmacological potential of Abrus precatorius L.: A review.

Authors:  Narendra Garaniya; Atul Bapodra
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  Integrating Network Pharmacology and Molecular Docking Approaches to Decipher the Multi-Target Pharmacological Mechanism of Abrus precatorius L. Acting on Diabetes.

Authors:  Fatima Noor; Abdur Rehman; Usman Ali Ashfaq; Muhammad Hamzah Saleem; Mohammad K Okla; Abdulrahman Al-Hashimi; Hamada AbdElgawad; Sidra Aslam
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-29

3.  Cytotoxic and pro-apoptotic effects of Abrus precatorius L. on human metastatic breast cancer cell line, MDA-MB-231.

Authors:  Mohammed Shafi Sofi; M K Sateesh; Mohsin Bashir; G Harish; T R Lakshmeesha; S Vedashree; A B Vedamurthy
Journal:  Cytotechnology       Date:  2012-10-19       Impact factor: 2.058

4.  Corilagin Attenuates Allergy and Anaphylactic Reaction by Inhibiting Degranulation of Mast Cells.

Authors:  Jie Zhou; Ci'an Zhang; Yuanyuan Sun; Li Wang; Jian Zhang; Fulun Li; Weian Mao
Journal:  Med Sci Monit       Date:  2018-02-13

5.  Antiasthmatic related properties of Abrus precatorius leaves on various models.

Authors:  Dnyaneshwar J Taur; Rajendra N Patil; Ravindra Y Patil
Journal:  J Tradit Complement Med       Date:  2017-01-12

6.  In Vivo Pharmacological Testing of Herbal Drugs for Anti-Allergic and Anti-Asthmatic Properties.

Authors:  Naiyer Shahzad; Abdullah R Alzahrani; Ibrahim Abdel Aziz Ibrahim; Kriti Soni; Imran Shahid; Safaa Mohammed Alsanosi; Alaa Falemban; Ibrahim Mufadhi M Alanazi; Ghazi A Bamagous; Saeed Saeed Al-Ghamdi; Amal M Mahfoz
Journal:  J Pharm Bioallied Sci       Date:  2022-03-04

7.  In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms.

Authors:  Balungile Madikizela; Ashwell Rungano Ndhlala; Jeffrey Franklin Finnie; Johannes Van Staden
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-05       Impact factor: 2.629

Review 8.  Traditional medicinal plants used for respiratory disorders in Pakistan: a review of the ethno-medicinal and pharmacological evidence.

Authors:  Waqas Younis; Hira Asif; Amber Sharif; Humayun Riaz; Ishfaq Ali Bukhari; Asaad Mohamed Assiri
Journal:  Chin Med       Date:  2018-09-18       Impact factor: 5.455

9.  Abrus precatorius Leaf Extract Reverses Alloxan/Nicotinamide-Induced Diabetes Mellitus in Rats through Hormonal (Insulin, GLP-1, and Glucagon) and Enzymatic (α-Amylase/α-Glucosidase) Modulation.

Authors:  Alex Boye; Victor Yao Atsu Barku; Desmond Omane Acheampong; Eric Gyamerah Ofori
Journal:  Biomed Res Int       Date:  2021-07-23       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.